| scholarly article | Q13442814 |
| P2093 | author name string | Yi Wang | |
| Chao You | |||
| Xiang Gao | |||
| Ting Yu | |||
| Xiaoxiao Liu | |||
| Tianying Zheng | |||
| Songping Zheng | |||
| P2860 | cites work | Mesenchymal stromal cells loading curcumin-INVITE-micelles: a drug delivery system for neurodegenerative diseases. | Q53357491 |
| Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome. | Q55460423 | ||
| SAR Studies on Curcumin’s Pro-inflammatory Targets: Discovery of Prenylated Pyrazolocurcuminoids as Potent and Selective Novel Inhibitors of 5-Lipoxygenase | Q60684400 | ||
| Pharmacokinetics of curcumin-loaded PLGA and PLGA–PEG blend nanoparticles after oral administration in rats | Q61047002 | ||
| Inulin-d-α-Tocopherol Succinate (INVITE) Nanomicelles as a Platform for Effective Intravenous Administration of Curcumin | Q63973071 | ||
| Application of nanotechnology in cancer therapy and imaging | Q80566445 | ||
| Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability | Q87098220 | ||
| IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype | Q29617457 | ||
| Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment | Q30736567 | ||
| Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide | Q33410559 | ||
| The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation | Q33606422 | ||
| Preparation of Tacrolimus loaded micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone). | Q33798884 | ||
| Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells | Q33831661 | ||
| Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer | Q34454413 | ||
| ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial disease. | Q34762292 | ||
| Phase II trial of curcumin in patients with advanced pancreatic cancer | Q34796370 | ||
| Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly(ethylene glycol)-poly(D,L-lactide) nanoparticle with longer survival time. | Q35029079 | ||
| Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma | Q36561184 | ||
| Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma | Q36562307 | ||
| Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo | Q36916903 | ||
| Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats | Q36931429 | ||
| Antiangiogenic therapies for high-grade glioma | Q37614203 | ||
| Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer | Q37616813 | ||
| A neurocentric perspective on glioma invasion | Q37638128 | ||
| Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges | Q37650693 | ||
| The amelioration of phagocytic ability in microglial cells by curcumin through the inhibition of EMF-induced pro-inflammatory responses | Q37715017 | ||
| Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects | Q37732204 | ||
| The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect | Q37742217 | ||
| Cancer nanotechnology: application of nanotechnology in cancer therapy | Q37781428 | ||
| Nanomedicine. | Q37821004 | ||
| Photoprotective efficiency of PLGA-curcumin nanoparticles versus curcumin through the involvement of ERK/AKT pathway under ambient UV-R exposure in HaCaT cell line | Q38800062 | ||
| CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro. | Q38893170 | ||
| Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway | Q38937276 | ||
| Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer | Q38960111 | ||
| EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy. | Q39135033 | ||
| Curcumin-derivative nanomicelles for the treatment of triple negative breast cancer. | Q39151176 | ||
| Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer | Q39264067 | ||
| Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites | Q39358580 | ||
| Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles | Q39496907 | ||
| The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma | Q39503654 | ||
| NFκB inhibitors induce cell death in glioblastomas. | Q39637390 | ||
| Targeted near-IR QDs-loaded micelles for cancer therapy and imaging. | Q39712307 | ||
| Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. | Q40144497 | ||
| Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice | Q40358890 | ||
| Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). | Q40397415 | ||
| Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis | Q41044426 | ||
| Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells | Q42971663 | ||
| Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer | Q43025626 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | curcumin | Q312266 |
| micelles | Q421110 | ||
| biodegradation | Q696715 | ||
| P304 | page(s) | 2721-2736 | |
| P577 | publication date | 2016-06-09 | |
| P1433 | published in | International Journal of Nanomedicine | Q6051502 |
| P1476 | title | Biodegradable micelles enhance the antiglioma activity of curcumin in vitro and in vivo | |
| P478 | volume | 11 |
| Q41890555 | A Glycyrrhetinic Acid-Modified Curcumin Supramolecular Hydrogel for liver tumor targeting therapy |
| Q33553570 | Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer |
| Q64072733 | Mitochondrial dysfunction mediated apoptosis of HT-29 cells through CS-PAC-AgNPs and investigation of genotoxic effects in zebra (Danio rerio) fish model for drug delivery |
| Q52584448 | Poly(Ethylene Glycol)-Polylactide Micelles for Cancer Therapy. |
| Q37469246 | Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment |
| Q59807306 | Preventive Effect of Curcumin Against Chemotherapy-Induced Side-Effects |
| Q37739993 | Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury |
Search more.